Evaluating [<sup>18</sup>F]FDG and [<sup>18</sup>F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models

Evaluating [<sup>18</sup>F]FDG and [<sup>18</sup>F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models

Breast cancer (BC) is the most frequent cancer and the second leading cause of death in women. A typical feature of BC cells is the metabolic shift toward increased glycolysis, which has become an interesting therapeutic target for metabolic drugs such as metformin (MET). Recently, the administratio...

Full description

Bibliographic Details
Main Authors: Paolo Rainone, Silvia Valtorta, Chiara Villa, Sergio Todde, Massimiliano Cadamuro, Gloria Bertoli, Donatella Conconi, Marialuisa Lavitrano, Rosa Maria Moresco
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:International Journal of Molecular Sciences
Subjects:
breast cancer
targeted therapy
prognostic biomarkers
PET/CT
metformin
syrosingopine
Online Access:https://www.mdpi.com/1422-0067/24/18/14124

Internet

https://www.mdpi.com/1422-0067/24/18/14124

Similar Items